Search Results
Dec 17, 2025, 10:50 ET Evoke Pharma and QOL Medical Announce Expiration of Tender Offer
metoclopramide include: Tardive dyskinesia (TD), other extrapyramidal effects (EPS), parkinsonism symptoms, motor restlessness, neuroleptic malignant syndrome (NMS), depression, suicidal ideation and suicide, hypertension, fluid retention, hyperprolactinemia, effects on the ability to drive and operate machinery.
More news about: QOL Medical, LLC
Dec 17, 2025, 10:00 ET EMASS Pushes the Edge Further with 16nm ECS-DoT
ultra-low-power Edge AI by extending always-on intelligence into more demanding and highly integrated applications. The new 16nm ECS-DoT builds on the 22nm's performance, energy consumption, compute capability and on-chip resources, while preserving the architectural concepts, developer workflow and ultra-low-power
More news about: EMASS
Dec 09, 2025, 12:00 ET Ekinops Introduces 32-Degree ROADM for High Baud Rate Channel Support and Muxless Designs
C-band."Compatible with both the C600HC and new C700HC chassis (see separate press release) the PM_ROADM-FLEX-H32M is managed through Celestis NMS, Ekinops advanced network management system.For more information about the Ekinops portfolio, please visit
More news about: Ekinops
Dec 09, 2025, 12:00 ET Ekinops New C700HC Chassis Efficiently Connects the Data Center and the Central Office
power option allows it to be located inside the data center that utilizes a hot and cold aisle layout system. Under the control of Ekinops' Celestis NMS network management system, the C700HC is fully interoperable with existing Ekinops chassis already deployed with complete service visibility, end-to-end
More news about: Ekinops
Nov 20, 2025, 08:30 ET Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules
lightheadedness, or fainting or feeling like you are going to faint. Neuroleptic Malignant Syndrome (NMS). NMS is a serious condition that can lead to death. Call a healthcare provider right away or go to the nearest emergency room if you develop these symptoms
More news about: Neurocrine Biosciences, Inc.
Nov 19, 2025, 09:00 ET CT Plan Requests Three-Week Extension on Fee Schedule Filing
New NMS Market Data Plan Asks SEC for Exemptive Relief NEW YORK, Nov. 19, 2025 /PRNewswire/ -- The Operating
More news about: CT Plan
Nov 13, 2025, 20:00 ET 楊文蔚演繹健絡通新廣告 與黃天賜教授對談運動復康
此處下載高解像度圖片：https://shorturl.at/nMs45 楊文蔚作為香港體壇標誌性人物，近年持續面對傷患與慢性痛症挑戰，於高強度訓練與康復過程間不斷尋求平衡。她在對談中坦言，身體不適不僅影響競技表
More news about: 健絡通藥業
Nov 13, 2025, 11:11 ET QUODD and Stocktwits Partner to Bring Real-Time 24x5 U.S. Market Data to Global Investor Community
Overnight API delivers comprehensive, real–time pricing and quote data sourced from Blue Ocean ATS (BOATS). QUODD's API covers all National Market System (NMS) securities, including second-level resolution bars, customizable chart data, and multi–identifier support (symbol, CUSIP, ISIN) for seamless integration.
More news about: QUODD
Nov 12, 2025, 07:30 ET Native Sun and OATI partner to advance tribal energy sovereignty with smart EV charging and microgrid technologies
Charge Station Network Management System (NMS) A robust EV driver mobile app, EVolution Full professional services for rollout and ongoing operations 24/7 support for reliability and customer service With the EVolution NMS hosted in the OATI Cloud, designed specifically
More news about: Open Access Technology International, Inc. (OATI)
Nov 06, 2025, 08:44 ET EnGenius Releases Broadband Outdoor EOC620 Mobile CPE for Transportation and Remote Operations
models, enabling operators to manage their entire network—from backbone to last-mile to mobile deployments—through a single centralized system. SkyPoint NMS and SkyConnect mobile app provide consistent tools for deployment, monitoring, and fleet management across all EOC products.
More news about: EnGenius Technologies, Inc.
Nov 06, 2025, 07:30 ET FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
people with dementia-related psychosis that can lead to death. Neuroleptic malignant syndrome (NMS): high fever, confusion, changes in your breathing, heart rate, and blood pressure, stiff muscles, and increased sweating; these may be symptoms of
More news about: Johnson & Johnson
Oct 17, 2025, 08:30 ET Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules
lightheadedness, or fainting or feeling like you are going to faint. Neuroleptic Malignant Syndrome (NMS). NMS is a serious condition that can lead to death. Call a healthcare provider right away or go to the nearest emergency room if you develop these symptoms
More news about: Neurocrine Biosciences, Inc.
Oct 10, 2025, 09:00 ET Blue Ocean Technologies to Pursue Tokenized NMS US Equities Trading
markets fintech leader in global trading and data, announced today its intent to pursue integration with the forthcoming tokenized National Market System (NMS) equities solution. This development positions Blue Ocean ATS as the first alternative trading system to support the trading of tokenized U.S. equities
More news about: Blue Ocean Technologies, LLC
Oct 10, 2025, 07:30 ET Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
Neuroleptic Malignant Syndrome (NMS). NMS is a rare but very serious problem that can happen in people who receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. NMS can cause death and must be treated in a hospital. Call your healthcare
More news about: Johnson & Johnson
Oct 07, 2025, 13:40 ET Health & Wellness Partners Appoints Nick Price as Chief Operating Officer, Bringing Global Agency Leadership from Klick
About NMS Capital Founded in 2010, NMS Capital is a seasoned private equity firm managing over $1.5 billion in assets. With a focus on Business Services and Healthcare Services, NMS has partnered with management teams across
More news about: Health & Wellness Partners
Oct 07, 2025, 08:30 ET Blue Ocean Technologies Integrates Real-Time Overnight Data into NYSE Cloud Streaming
trading hours. Blue Ocean ATS, LLC, and its trading system Blue Ocean Alternative Trading System (BOATS), currently trade US National Market System (NMS) stocks from 8:00 pm to 4:00 am ET from Sunday – Thursday. Founded in 2019, Blue Ocean ATS is on a mission to transform US trading to Global trading
More news about: Blue Ocean Technologies, LLC
Oct 06, 2025, 09:00 ET Blue Ocean Technologies Announces Promotion of John Willock to Chief Revenue Officer
trading hours. Blue Ocean ATS, LLC, and its trading system Blue Ocean Alternative Trading System (BOATS), currently trade US National Market System (NMS) stocks from 8:00 pm to 4:00 am ET from Sunday – Thursday. Founded in 2019, Blue Ocean ATS is on a mission to transform US trading to Global trading
More news about: Blue Ocean Technologies, LLC
Oct 06, 2025, 08:30 ET Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea
fainting or feeling like you are going to faint. Neuroleptic Malignant Syndrome (NMS). NMS is a serious condition that can lead to death. Call a healthcare provider right away or go to the nearest emergency room if you develop these symptoms
More news about: Neurocrine Biosciences, Inc.
Sep 30, 2025, 09:00 ET CT Plan Issues RFP for Independent Administrator
New NMS market data plan seeks firm to oversee administration ahead of its 2027 launch NEW YORK, Sept. 30, 2025
More news about: CT Plan
Sep 29, 2025, 13:00 ET Blue Ocean Technologies Real-Time Overnight Trading Data Now Available via Bloomberg Solutions
trading hours. Blue Ocean ATS, LLC, and its trading system Blue Ocean Alternative Trading System (BOATS), currently trade US National Market System (NMS) stocks from 8:00 pm to 4:00 am ET from Sunday – Thursday. Founded in 2019, Blue Ocean ATS is on a mission to transform US trading to Global trading
More news about: Blue Ocean Technologies, LLC
Sep 23, 2025, 08:30 ET Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden
shortness of breath, dizziness or lightheadedness, or fainting or feeling like you are going to faint.Neuroleptic Malignant Syndrome (NMS). NMS is a serious condition that can lead to death. Call a healthcare provider right away or go to the nearest emergency room if you develop these symptoms
More news about: Neurocrine Biosciences, Inc.
Sep 17, 2025, 08:34 ET Dream Exchange Presents at National Society of Black Engineers Conference in New Orleans
Kris Bell addressed how Dream Exchange's proposed exchange, which will be trading securities in the National Market System ("NMS") and currently in formation, will help engineers with promising ideas access the capital they need to expand their businesses and benefit the world.
More news about: Dream Exchange
Sep 15, 2025, 08:00 ET Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
can lead to deathNeuroleptic Malignant Syndrome (NMS). NMS is a rare but very serious problem that can happen in people who receive INVEGA HAFYERA®, INVEGA TRINZA® or INVEGA SUSTENNA®. NMS can cause death and must be treated in a hospital. Call your healthcare
More news about: Johnson & Johnson
Sep 15, 2025, 07:23 ET Teleste Launches Argus NMS Web UI -- With Integrated Maps and Zero-Install Access
https://news.cision.com/teleste-corporation/i/teleste-argus-nms-webui-cision,c3469572 Teleste Argus NMS WebUI cision
More news about: Teleste Corporation
Sep 15, 2025, 07:17 ET Teleste Launches Argus NMS Web UI -- With Integrated Maps and Zero-Install Access
https://news.cision.com/teleste-corporation/i/teleste-argus-nms-webui-cision,c3469572 Teleste Argus NMS WebUI cision
More news about: Teleste Corporation